Clinical impact of PET/MRI in oligometastatic colorectal cancer.

ABSTRACT:

Background

Oligometastatic colorectal cancer (CRC) is potentially curable and demands individualised strategies.

Methods

This single-centre retrospective study investigated if positron emission tomography (PET)/magnetic resonance imaging (MR) had a clinical impact on oligometastatic CRC relative to the standard of care imaging (SCI). Adult patients with oligometastatic CRC on SCI who also underwent PET/MR between 3/2016 and 3/2019 were included. The exclusion criterion was lack of confirmatory standard of reference, either surgical pathology, intraoperative gross confirmation or imaging follow-up. SCI consisted of contrast-enhanced (CE) computed tomography (CT) of the chest/abdomen/pelvis, abdominal/pelvic CE-MR, and/or CE whole-body PET/CT with diagnostic quality (i.e. stan

SUBMITTER: Furtado FS 

PROVIDER: S-EPMC8476553 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature